| NCT Number | NCT06089408 |
| Lead Sponsor | Ohio State University Comprehensive Cancer Center |
| Conditions | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 114 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2027-06-30 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-05 |